Intuitive Surgical, Inc. (ISRG) Stock Analysis
Is ISRG a good investment?
Intuitive Surgical, Inc. (ISRG) has a Plutrex AI rating of 80.0/100 as of July 11, 2026, indicating a Strong Buy consensus. The stock is not classified as halal-compliant. Key strength: Industry-dominant profitability: 66.3% gross margins and 30.9% operating margins vastly superior to struggling industry peers posting losses. Main concern: PEG ratio of 2.45 indicates overvaluation with investors paying 2.45x the growth rate, though improved from prior 2.52.
Investment Summary
ISRG remains a premium medical device leader with exceptional fundamentals: 66.3% gross margins (vs 59.4% industry), 30.9% operating margins (vs -1.9% industry), debt-free balance sheet with $4.5B cash, and 17.2% ROE. However, PEG ratio of 2.45 indicates overvaluation despite improvement from 2.52. Stock declined 4.7% to $407.50, creating better entry opportunity while maintaining 39.9% upside to $570.19 analyst target. News sentiment at 67.9/100 shows neutral-to-positive outlook with strong Q1 2026 system placements of 431 units.
Key Strengths
- Industry-dominant profitability: 66.3% gross margins and 30.9% operating margins vastly superior to struggling industry peers posting losses
- Fortress balance sheet with zero debt and $4.5B cash providing maximum financial flexibility and recession resilience
- Strong market position with 431 da Vinci system placements in Q1 2026 demonstrating continued demand for robotic surgery solutions
Key Concerns
- PEG ratio of 2.45 indicates overvaluation with investors paying 2.45x the growth rate, though improved from prior 2.52
- Growth deceleration from historical 25.9% EPS growth to projected 13.3% forward growth signals business maturation phase
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
ISRG demonstrates industry-leading profitability with gross margins of 66.3% (11.6% above industry 59.4%), operating margins of 30.9% (vs industry losses of -1.9%), and net margins of 28.1% (vs industry -12.1%). ROE of 17.2% significantly outperforms industry's -19.8%. Balance sheet strength is exceptional with zero debt and $4.5B cash providing maximum flexibility. Growth metrics show deceleration: forward EPS growth of 13.3% vs historical 25.9%, but 5-year projected growth of 14.2% remains solid. Valuation concern persists with PEG ratio of 2.45 (improved from 2.52) and P/E of 49.86, indicating premium pricing despite quality fundamentals.
News Sentiment
Intuitive Surgical finds itself at a crossroads as the robotic surgery pioneer navigates both opportunities and challenges in 2026. The company delivered strong operational results with 431 da Vinci system placements in Q1 2026, signaling robust demand for its surgical robots despite a challenging market environment. However, questions are emerging about whether this represents genuine demand strength or simply the peak of an upgrade cycle. Recent analyst upgrades to 'Buy' ratings reflect growing confidence in ISRG's financial outlook, with several firms highlighting the company's ability to leverage costs amid potential tariff and input inflation pressures. Yet competitive concerns are mounting, with new robotics companies attempting to challenge ISRG's market dominance. The stock has faced headwinds in 2026, creating what some analysts view as an attractive buying opportunity for long-term investors. Rising trade-ins suggest existing customers are upgrading their systems, indicating strong customer loyalty and the stickiness of ISRG's ecosystem. For investors, the key question remains whether the current valuation reflects the company's transition from high-growth startup to mature market leader, or if there's still room for the stock to run higher.
Risk Assessment
Primary risks include valuation premium with PEG of 2.45 making stock vulnerable to growth disappointments, competitive threats from emerging robotics companies as noted in news, and potential margin pressure from tariff/input inflation. Mitigation comes from strong competitive moat, debt-free balance sheet providing flexibility, and consistent system placement growth indicating market demand resilience.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is ISRG a halal stock?
No, Intuitive Surgical, Inc. (ISRG) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for ISRG?
Intuitive Surgical, Inc. (ISRG) has a Plutrex AI rating of 80.0/100 with a Strong Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is ISRG a good investment?
According to Plutrex AI, ISRG has a Strong Buy rating (80.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in ISRG?
US stocks like ISRG can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in ISRG?
Plutrex AI identifies the main risks for ISRG by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.